Cryoglobulinemia;Les cryoglobulinémies

Revue de Medecine Interne

Volumn 29, Issue 3, 2008, Pages 200-208

  Cacoub, P ^a,b   Sene D ^a   Saadoun, D ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Unit of Dermatology   (France)

Author keywords

Cryoglobulinemia; Hepatitis C virus; Interferon alpha; Rituximab; Vasculitis

Indexed keywords

PEGINTERFERON; RIBAVIRIN; RITUXIMAB; ALPHA INTERFERON; ANTIVIRUS AGENT; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY COMPLEX; CELLULAR IMMUNITY; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CRYOGLOBULINEMIA; DRUG EFFECT; DRUG RESEARCH; HUMAN; HUMORAL IMMUNITY; SHORT SURVEY; SYSTEMIC VASCULITIS; TREATMENT OUTCOME; VASCULITIS; COMPARATIVE STUDY; DRINKING BEHAVIOR; DRUG COMBINATION; FATTY LIVER; FEMALE; HEPATITIS C; IMMUNOLOGY; LIVER CIRRHOSIS; MALE; RECURRENT DISEASE; REVIEW; SEX DIFFERENCE; VIROLOGY;

ALCOHOL DRINKING; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; DRUG THERAPY, COMBINATION; FATTY LIVER; FEMALE; HEPATITIS C; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; LIVER CIRRHOSIS; MALE; RECURRENCE; RIBAVIRIN; SEX FACTORS; VASCULITIS;

EID: 42149122670     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.10.416     Document Type: Short Survey

References (60)

1. Wintrobe M.M., and Buell M.V. Hyperproteinemia associated with multiple myeloma. Bull Johns Hopkins Hosp 52 (1933) 156
2. Musset L., Diemert M.C., Taibi F., Thi Huong Du L., Cacoub P., Leger J.M., et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 38 (1992) 798-802
3. Brouet J.C., Clauvel J.P., Danon F., Klein M., and Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57 (1974) 775-788
4. Blain H., Cacoub P., Musset L., Costedoat-Chalumeau N., Silberstein C., Chosidow O., et al. Cryofibrinogenaemia: a study of 49 patients. Clin Exp Immunol 120 (2000) 253-260
5. Monti G., Galli M., Invernizzi F., Pioltelli P., Saccardo F., Monteverde A., et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. Q J Med 88 (1995) 115-126
6. Trejo O., Ramos-Casals M., Garcia-Carrasco M., Yague J., Jimenez S., de la Red G., et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80 (2001) 252-262
7. Saadoun D., Sellam J., Ghillani-Dalbin P., Crecel R., Piette J.C., and Cacoub P. Increased risks of lymphoma and death among patients with non-hepatitis C virus-related mixed cryoglobulinemia. Arch Intern Med 166 (2006) 2101-2108
8. Gorevic P.D., Kassab H.J., Levo Y., Kohn R., Meltzer M., Prose P., et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 69 (1980) 287-308
9. Zarski J.P., Rougier D., Aubert H., Renversez J.C., Cordonnier D., Stoebner P., et al. Association of cryoglobulins and hepatic disease: incidence, nature and immunochemical characteristics of cryoglobulinemia. Gastroenterol Clin Biol 8 (1984) 845-850
10. Ferri C., Greco F., Longombardo G., Palla P., Moretti A., Marzo E., et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Arthritis Rheum 34 (1991) 1606-1610
11. Agnello V., Chung R.T., and Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327 (1992) 1490-1495
12. Cacoub P., Fabiani F.L., Musset L., Perrin M., Frangeul L., Leger J.M., et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96 (1994) 124-132
13. Pawlotsky J.M., Ben Yahia M., Andre C., Voisin M.C., Intrator L., Roudot-Thoraval F., et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19 (1994) 841-848
14. Cacoub P., Poynard T., Ghillani P., Charlotte F., Olivi M., Piette J.C., et al. Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 42 (1999) 2204-2212
15. Cacoub P., Renou C., Rosenthal E., Cohen P., Loury I., Loustaud-Ratti V., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine (Baltimore) 79 (2000) 47-56
16. Nagai T., Nagai T., and Okazaki T. Relationship between cryoglobulins and hepatitis C virus (HCV) core antigen or antibody titers. Clin Chem Lab Med 42 (2004) 105-106
17. Saadoun D., Asselah T., Resche-Rigon M., Charlotte F., Bedossa P., Valla D., et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 43 (2006) 1337-1345
18. Sène D., Ghillani-Dalbin P., Thibault V., Guis L., Musset L., Duhaut P., et al. Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J Rheumatol 31 (2004) 2199-2206
19. Cacoub P., Renou C., Kerr G., Hue S., Rosenthal E., Cohen P., et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44 (2001) 2118-2124
20. De Re V., De Vita S., Marzotto A., Gloghini A., Pivetta B., Gasparotto D., et al. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer 87 (2000) 211-216
21. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., et al. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
22. Sasso E.H., Martinez M., Yarfitz S.L., Ghillani P., Musset L., Piette J.C., et al. Frequent joining of Bcl-2 to a JH6 gene in hepatitis C virus-associated t(14;18). J Immunol 173 (2004) 3549-3556
23. Zignego A.L., Ferri C., Giannelli F., Giannini C., Caini P., Monti M., et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 137 (2002) 571-580
24. Giannelli F., Moscarella S., Giannini C., Caini P., Monti M., Gragnani L., et al. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 102 (2003) 1196-1201
25. Sène D., Limal N., Ghillani-Dalbin P., Saadoun D., Piette J.C., and Cacoub P. Hepatitis C virus-associated B-cell proliferation-the role of serum B lymphocyte stimulator (BLyS/BAFF). Rheumatology (Oxford) 46 (2007) 65-69
26. Cacoub P., Maisonobe T., Thibault V., Gatel A., Servan J., Musset L., et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 28 (2001) 109-118
27. Authier F.J., Bassez G., Payan C., Guillevin L., Pawlotsky J.M., Degos J.D., et al. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 60 (2003) 808-812
28. De Martino L., Sampaolo S., Tucci C., Ambrosone L., Budillon A., Migliaresi S., et al. Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve 27 (2003) 102-104
29. Boyer O., Saadoun D., Abriol J., Dodille M., Piette J.C., Cacoub P., et al. CD4 + CD25+ regulatory T cells deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103 (2004) 3428-3430
30. Kaplanski G., Marin V., Maisonobe T., Sbai A., Farnarier C., Ghillani P., et al. Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia. Clin Exp Immunol 127 (2002) 123-130
31. Saadoun D., Boyer O., Trebeden-Negre H., Limal N., Bon-Durand V., Andreu M., et al. Predominance of type 1 (Th1) cytokine production in the liver of patients with HCV-associated mixed cryoglobulinemia vasculitis. J Hepatol 41 (2004) 1031-1037
32. Saadoun D., Bieche I., Maisonobe T., Asselah T., Laurendeau I., Piette J.C., et al. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 52 (2005) 2917-2925
33. Saadoun D., Bieche I., Authier F.J., Laurendeau I., Jambou F., Piette J.C., et al. Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 56 (2007) 1315-1324
34. Roccatello D., Baldovino S., Rossi D., Mansouri M., Naretto C., Gennaro M., et al. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis. Nephrol Dial Transplant 19 (2004) 3054-3061
35. Fornasieri A., Li M., Armelloni S., de Septis C.P., Schiaffino E., Sinico R.A., et al. Glomerulonephritis induced by human IgMK-IgG cryoglobulins in mice. Lab Invest 69 (1993) 531-540
36. Sabbatini A., Dolcher M.P., Marchini B., Chimenti D., Moscato S., Pratesi F., et al. Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin Exp Rheumatol 15 (1997) 655-658
37. Migliorini P., Pratesi F., Moscato S., Bongiorni F., and Bombardieri S. Mechanisms of renal damage in mixed cryoglobulinaemia nephritis. Nephrol Dial Transplant 16 Suppl 6 (2001) 58-59
38. Cresta P., Musset L., Cacoub P., Frangeul L., Vitour D., Poynard T., et al. Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus. Gut 45 (1999) 122-128
39. Meltzer M., Franklin E.C., Elias K., McCluskey R.T., and Cooper N. Cryoglobulinemia-a clinical and laboratory study II. Cryoglobulins with rheumatoid factor activity. Am J Med 40 (1966) 837-856
40. Dupin N., Chosidow O., Lunel F., Cacoub P., Musset L., Cresta P., et al. Essential mixed cryoglobulinemia. A comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch Dermatol 131 (1995) 1124-1127
41. Leone N., Pellicano R., Ariata Maiocco I., Modena V., Marietti G., Rizzetto M., et al. Mixed cryoglobulinaemia and chronic hepatitis C virus infection: the rheumatic manifestations. J Med Virol 66 (2002) 200-203
42. Sène D., Ghillani-Dalbin P., Limal N., Thibault V., van Boekel T., Piette J.C., et al. Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome. Ann Rheum Dis 65 (2006) 394-397
43. Cacoub P., Ratziu V., Myers R.P., Ghillani P., Piette J.C., Moussalli J., et al. Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C. J Hepatol 36 (2002) 812-818
44. Apartis E., Leger J.M., Musset L., Gugenheim M., Cacoub P., Lyon-Caen O., et al. Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection?. J Neurol Neurosurg Psychiatry 60 (1996) 661-666
45. Nemni R., Sanvito L., Quattrini A., Santuccio G., Camerlingo M., and Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 74 (2003) 1267-1271
46. Casato M., Saadoun D., Marchetti A., Picq C., Pantano P., Dormont D., et al. Central nervous system involvement in hepatitis C virus cryoglobulinemia vasculitis: a multicenter case-control study using magnetic resonance imaging and neuropsychological tests. J Rheumatol 32 (2005) 484-488
47. Beddhu S., Bastacky S., and Johnson J.P. The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 81 (2002) 398-409
48. Fabrizi F., Colucci P., Ponticelli C., and Locatelli F. Kidney and liver involvement in cryoglobulinemia. Semin Nephrol 22 (2002) 309-318
49. Tarantino A., Campise M., Banfi G., Confalonieri R., Bucci A., Montoli A., et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47 (1995) 618-623
50. Roccatello D., Fornasieri A., Giachino O., Rossi D., Beltrame A., Banfi G., et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49 (2007) 69-82
51. Ferri C., Sebastiani M., Giuggioli D., Cazzato M., Longombardo G., Antonelli A., et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 33 (2004) 355-374
52. Saadoun D., Landau D.A., Calabrese L.H., and Cacoub P.P. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lympholiferation. Rheumatology 46 (2007) 1234-1242
53. Gisbert J.P., Garcia-Buey L., Pajares J.M., and Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 125 (2003) 1723-1732
54. Hermine O., Lefrere F., Bronowicki J.P., Mariette X., Jondeau K., Eclache-Saudreau V., et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347 (2002) 89-94
55. Saadoun D., Suarez F., Lefrere F., Valensi F., Mariette X., Aouba A., et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?. Blood 105 (2005) 74-76
56. Monti G., Pioltelli P., Saccardo F., Campanini M., Candela M., Cavallero G., et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 165 (2005) 101-105
57. Saadoun D, Delluc A, Piette JC, Cacoub P. Treatment of hepatitis C virus mixed cryoglobulinemia. Current Op Rheumatol, 2007 (in press).
58. Cacoub P., Saadoun D., Limal N., Sene D., Lidove O., and Piette J.C. PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 52 (2005) 911-915
59. Saadoun D., Resche-Rigon M., Thibault V., Piette J.C., and Cacoub P. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow-up study. Arthritis Rheum 54 (2006) 3696-3706
60. Cacoub P, Delluc A, Saadoun D, Landau DA, Sene D. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemia vasculitis: where do we stand? Ann Rheum Dis. 2007; [Epub ahead of print].